Empirico · 1 month ago
Scientist - CMC
Empirico is a clinical-stage biotechnology company focused on siRNA medicines. They are seeking a chemist to support the synthesis and characterization of oligonucleotides, with responsibilities including process development and technology transfer to CDMOs.
BiotechnologyLife ScienceMedical
Responsibilities
Perform solid-phase synthesis, purification, and characterization of oligonucleotides
Develop and optimize scalable upstream (synthesis) and downstream (purification, formulation) manufacturing processes
Support process development activities to enable successful technology transfer to CDMOs
Analyze, interpret, and clearly communicate synthetic and analytical data
Present findings to senior staff and cross-functional teams
Troubleshoot and refine synthesis and purification protocols
Manage multiple projects simultaneously
Qualification
Required
BS in Chemistry with at least 7 years of relevant industry experience, or an MS in Organic Chemistry, Biochemistry, or Chemical Engineering with a minimum of 3 years of experience, or a PhD with at least 1 year of relevant experience
Minimum 1 year of experience working in a cGMP environment
Hands-on proficiency with analytical instrumentation such as NMR, LC-MS, and RP-HPLC
1–7 years of relevant work experience, preferably in solid-phase oligonucleotide synthesis, and familiarity with both upstream and downstream oligonucleotide manufacturing processes
Demonstrated ability in analytical and purification method development using RPIP-HPLC, AEX-HPLC, UV, MALDI, and HRMS
Background in process development and technology transfer to CDMOs, including development of scalable purification and formulation methodologies
Working knowledge of tangential flow filtration (TFF) method development
Applicants must have authorization to work in the U.S
Benefits
Retirement savings plan (with company match)
Paid vacation
Holidays
Health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans
Company
Empirico
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
Funding
Current Stage
Growth StageTotal Funding
$74.72M2023-03-20Series B· $45.22M
2020-01-09Series A· $17M
2018-11-01Series A· $12.5M
Recent News
Labiotech UG
2025-11-08
2025-10-31
2025-10-31
Company data provided by crunchbase